Related Experiment Videos
Reduction of polypharmacy by feedback to clinicians
T J Meyer1, D Van Kooten, S Marsh
1Department of Medicine, Denver VA Medical Center, Colorado 80220.
Journal of General Internal Medicine
|March 1, 1991
Summary
A simple intervention significantly reduced polypharmacy in outpatients taking 10+ medications. More complex interventions did not show further benefits, and effects diminished by six months.
Area of Science:
- Geriatric Medicine
- Clinical Pharmacy
- Health Services Research
Background:
- Polypharmacy is a significant issue in older adults, increasing risks of adverse events and healthcare costs.
- Managing multiple medications in outpatients requires effective interventions to ensure patient safety and optimize treatment.
Purpose of the Study:
- To evaluate the effectiveness of two educational interventions in reducing polypharmacy among outpatients prescribed ten or more medications.
- To compare a simple notification strategy against a more intensive intervention for medication reduction.
Main Methods:
- A randomized controlled trial involving 292 outpatients with polypharmacy at the Denver Veterans Affairs Center.
- Interventions included simple provider notification, intensive notification with chart review and recommendations, and a control group.
- Outcomes were measured by the reduction in the number of active medications at four and six months.
Main Results:
- The simple notification group demonstrated a significant reduction in polypharmacy compared to the control group at four months (p = 0.028).
- No significant difference in medication reduction was observed between the simple and intensive intervention groups (p = 0.189).
- The significant difference in polypharmacy reduction between groups was not sustained by six months.
Conclusions:
- A straightforward educational intervention can effectively reduce polypharmacy in high-risk outpatient populations.
- Intensifying the intervention did not yield superior results in reducing medication burden.
- The sustainability of polypharmacy reduction beyond four months requires further investigation.